Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Iteos Therapeutics Inc (ITOS)

Iteos Therapeutics Inc (ITOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
NCR Atleos Set to Join S&P SmallCap 600 PR Newswire - Wed Oct 11, 2023

/PRNewswire/ -- NCR Atleos Corp. (NYSE: NATL) will replace iTeos Therapeutics Inc. (NASD: ITOS) in the S&P SmallCap 600 effective prior to the opening of...

SPGI : 412.56 (-0.20%)
ITOS : 10.56 (+2.23%)
NATL : 21.06 (+0.33%)
NCR : 27.08 (+3.24%)
VYX : 11.94 (-1.32%)
New Drugs in Fight Against Cancer Being Powered by Novel Mechanisms of Action FinancialNewsMedia - Thu Jun 8, 2023

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – June 8, 2023 – USA News Group  –  By utilizing newly developed novel mechanisms, biotech researchers and scientists are...

ONCY : 1.0600 (+2.91%)
ONC.TO : 1.44 (+0.70%)
GILD : 66.76 (+0.91%)
ITOS : 10.56 (+2.23%)
GSK : 39.75 (+1.22%)
PGEN : 1.3300 (+0.76%)
New Drugs in Fight Against Cancer Being Powered by Novel Mechanisms of Action PR Newswire - Thu Jun 8, 2023

/PRNewswire/ -- USA News Group - By utilizing newly developed novel mechanisms, biotech researchers and scientists are making strides in the battle against...

ONC.TO : 1.44 (+0.70%)
ONCY : 1.0600 (+2.91%)
GILD : 66.76 (+0.91%)
ITOS : 10.56 (+2.23%)
GSK : 39.75 (+1.22%)
PGEN : 1.3300 (+0.76%)
Novel Mechanisms Leading the Charge in Fight Against Cancer, Opening Door to New Drugs & Therapies BayStreet.ca - Thu Jun 8, 2023

USA News Group – By utilizing newly developed novel mechanisms, biotech researchers and scientists are making strides in the battle against cancer. A study put out by researchers at the University of...

ONCY : 1.0600 (+2.91%)
ONC.TO : 1.44 (+0.70%)
GILD : 66.76 (+0.91%)
ITOS : 10.56 (+2.23%)
GSK : 39.75 (+1.22%)
PGEN : 1.3300 (+0.76%)
ITeos Therapeutics, Inc. (ITOS) Reports Q1 Loss, Misses Revenue Estimates Zacks - Wed May 10, 2023

iTeos Therapeutics, Inc. (ITOS) delivered earnings and revenue surprises of 55.56% and 8.73%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

ITOS : 10.56 (+2.23%)
GERN : 3.69 (-1.07%)
Bluebird Bio (BLUE) Q1 Earnings Surpass Estimates Zacks - Tue May 9, 2023

Bluebird (BLUE) delivered earnings and revenue surprises of 138.89% and 89.61%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

BLUE : 1.0200 (+7.03%)
ITOS : 10.56 (+2.23%)
Dynavax Technologies (DVAX) Reports Q1 Loss, Tops Revenue Estimates Zacks - Tue May 2, 2023

Dynavax Technologies (DVAX) delivered earnings and revenue surprises of -58.33% and 21.35%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

DVAX : 11.80 (+4.06%)
ITOS : 10.56 (+2.23%)
ITeos Therapeutics, Inc. (ITOS) Q4 Earnings and Revenues Surpass Estimates Zacks - Wed Mar 15, 2023

iTeos Therapeutics, Inc. (ITOS) delivered earnings and revenue surprises of 35.71% and 30.97%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

ITOS : 10.56 (+2.23%)
LVTX : 2.71 (-4.24%)
Avidity Biosciences, Inc. (RNA) Reports Q4 Loss, Tops Revenue Estimates Zacks - Tue Feb 28, 2023

Avidity Biosciences, Inc. (RNA) delivered earnings and revenue surprises of -4.76% and 15.86%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

RNA : 22.73 (-1.35%)
ITOS : 10.56 (+2.23%)
ITeos Therapeutics, Inc. (ITOS) Lags Q3 Earnings and Revenue Estimates Zacks - Thu Nov 10, 2022

iTeos Therapeutics, Inc. (ITOS) delivered earnings and revenue surprises of -57.14% and 53.65%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

ITOS : 10.56 (+2.23%)
PDCO : 26.02 (+2.16%)

Barchart Exclusives

Bull or Bear? Where Corn, Wheat, and Soybean Price are Headed Barchart - 1 hour ago
Darin Newsom joins Bryce Doeschot on Market Journal to discuss the corn, wheat, soybean, and cattle markets. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot